Author:
Sabatino Joseph J.,Zamvil Scott S.,Hauser Stephen L.
Publisher
Cold Spring Harbor Laboratory
Subject
General Biochemistry, Genetics and Molecular Biology
Reference108 articles.
1. Agius M , Klodowska-Duda G , Maciejowski M , Potemkowski A , Sweeny S , Li J , Yao W , Patra K , Ratchford J , Katz E , 2015. Safety and tolerability of MEDI-551 in patients with relapsing forms of multiple sclerosis: Results from a phase 1 randomised, placebo-controlled, escalating intravenous and subcutaneous dose study. ECTRIMS P528.
2. Rituximab versus fingolimod after natalizumab in multiple sclerosis patients
3. Decreased Dicer expression is linked to increased expression of co-stimulatory molecule CD80 on B cells in multiple sclerosis
4. Memory B cells are major targets for effective immunotherapy in relapsing multiple sclerosis;EBioMedicine,2017
5. In multiple sclerosis, oligoclonal bands connect to peripheral B‐cell responses
Cited by
55 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献